Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug3872 | TCC-COVID mHealth solution Wiki | 1.00 |
| drug2552 | Nitazoxanide Wiki | 0.26 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
| D018352 | Coronavirus Infections NIH | 0.04 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
This is a randomised, multi-center, open label, adaptive, exploratory trial to assess the efficacy of two different drug regimens in terms of preventing symptomatic COVID-19 disease in healthcare workers at high risk of exposure to SARS-CoV-2. The trial will compare two different experimental medication arms to the control arm comprising the use of standard personal protective equipment (PPE) with no additional pharmacological intervention.
Description: Number of SARS-CoV-2 infection (COVID-19) confirmed by PCR and/or serology.
Measure: Number of SARS-CoV-2 infections Time: 6 monthsDescription: Duration of symptoms for each symptomatic infection
Measure: Duration of symptoms Time: 6 monthsDescription: Maximum score on WHO Ordinal Scale for Clinical Improvement for each symptomatic infection. Score of 0 being uninfected and a score of 8 being dead.
Measure: Maximum score on WHO Ordinal Scale Time: 6 monthsDescription: Time to onset of SARS-CoV-2 infection (COVID-19) confirmed by PCR and/or serology
Measure: Time to onset of SARS-CoV-2 infection Time: 6 monthsDescription: Number of symptomatic SARS-CoV-2 infection (COVID-19) confirmed by PCR and/or serology
Measure: Number of symptomatic SARS-CoV-2 infections Time: 6 monthsDescription: Number of asymptomatic • Asymptomatic SARS-CoV-2 infection suggested by serological outcome
Measure: Number of asymptomatic SARS-CoV-2 infections Time: 6 monthsDescription: Peak score on modified Flu-PRO during each symptomatic infection. 37-item questionairre assessing the severity of flu like symptoms one a scale of 0 - not at all to 5 - very much.
Measure: Peak score on modified Flu PRO Time: 6 monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports